112 related articles for article (PubMed ID: 38702288)
1. Development and in vitro antiviral activity of ivermectin liposomes as a potential drug carrier system.
Kocas M; Comoglu T; Ozkul A
Arch Pharm (Weinheim); 2024 May; ():e2300708. PubMed ID: 38702288
[TBL] [Abstract][Full Text] [Related]
2. Protection of hair color with pomegranate peel extract-loaded liposomal formulation: Preparation, characterization, and ex-vivo activity studies.
Tuncay Tanriverdi S; Gokce EH; Filiz SB; Kose FA; Ozer O
J Cosmet Dermatol; 2022 Nov; 21(11):6292-6301. PubMed ID: 35869815
[TBL] [Abstract][Full Text] [Related]
3. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
Shaji J; Menon I
Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
[TBL] [Abstract][Full Text] [Related]
4. Preclinical study of Doxorubicine-loaded liposomal drug delivery for the treatment of head and neck cancer: Optimization by Box-Behnken statistical design.
Yang B
Acta Biochim Pol; 2020 Jun; 67(2):149-155. PubMed ID: 32506868
[TBL] [Abstract][Full Text] [Related]
5. [Preparation and Characterization of Clopidogrel Bisulfate Liposomes].
Wu BQ; He YJ; Yin ZN; Zhang ZR; Deng L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 52(4):630-636. PubMed ID: 34323042
[TBL] [Abstract][Full Text] [Related]
6. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
Dadashzadeh S; Vali AM; Rezaie M
Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of liposome formulation parameters and their influence on encapsulation, stability and drug release in glibenclamide liposomes.
Maritim S; Boulas P; Lin Y
Int J Pharm; 2021 Jan; 592():120051. PubMed ID: 33161039
[TBL] [Abstract][Full Text] [Related]
8. Formulation design and optimization of cationic-charged liposomes of brimonidine tartrate for effective ocular drug delivery by design of experiment (DoE) approach.
Soni PK; Saini TR
Drug Dev Ind Pharm; 2021 Nov; 47(11):1847-1866. PubMed ID: 35484943
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of cefditoren pivoxil-loaded liposomes for controlled in vitro and in vivo drug release.
Venugopalarao G; Lakshmipathy R; Sarada NC
Int J Nanomedicine; 2015; 10 Suppl 1(Suppl 1):149-57. PubMed ID: 26491316
[TBL] [Abstract][Full Text] [Related]
10. Docetaxel-loaded liposomes: The effect of lipid composition and purification on drug encapsulation and in vitro toxicity.
Pereira S; Egbu R; Jannati G; Al-Jamal WT
Int J Pharm; 2016 Nov; 514(1):150-159. PubMed ID: 27863659
[TBL] [Abstract][Full Text] [Related]
11. Formulation of Metoclopramide Hydrochloride-Loaded Lipid Carriers by QbD Approach for Combating Nausea: Safety and Bioavailability Evaluation in New Zealand Rabbit.
Baranauskaite J; Aydin M; Uner B; Tas C
AAPS PharmSciTech; 2024 Apr; 25(4):73. PubMed ID: 38575825
[TBL] [Abstract][Full Text] [Related]
12. Microfluidic paclitaxel-loaded lipid nanoparticle formulations for chemotherapy.
Jaradat E; Weaver E; Meziane A; Lamprou DA
Int J Pharm; 2022 Nov; 628():122320. PubMed ID: 36272514
[TBL] [Abstract][Full Text] [Related]
13. Double Optimization of Rivastigmine-Loaded Nanostructured Lipid Carriers (NLC) for Nose-to-Brain Delivery Using the Quality by Design (QbD) Approach: Formulation Variables and Instrumental Parameters.
Cunha S; Costa CP; Loureiro JA; Alves J; Peixoto AF; Forbes B; Sousa Lobo JM; Silva AC
Pharmaceutics; 2020 Jun; 12(7):. PubMed ID: 32605177
[TBL] [Abstract][Full Text] [Related]
14. Development of ACE2 loaded decoy liposomes and their effect on SARS-CoV-2 for Covid-19 treatment.
Arisoy S; Kocas M; Comoglu T; Guderer I; Banerjee S
Pharm Dev Technol; 2022 Mar; 27(3):290-300. PubMed ID: 35156882
[TBL] [Abstract][Full Text] [Related]
15. Physicochemical characteristics of liposome encapsulation of stingless bees' propolis.
Ramli NA; Ali N; Hamzah S; Yatim NI
Heliyon; 2021 Apr; 7(4):e06649. PubMed ID: 33898810
[TBL] [Abstract][Full Text] [Related]
16. A Study of Liposomal Formulations to Improve the Delivery of Aquated Cisplatin to a Multidrug Resistant Tumor.
Zhao Y; May JP; Chen IW; Undzys E; Li SD
Pharm Res; 2015 Oct; 32(10):3261-8. PubMed ID: 25964047
[TBL] [Abstract][Full Text] [Related]
17. Co-delivery of doxorubicin and PSC 833 (Valspodar) by stealth nanoliposomes for efficient overcoming of multidrug resistance.
Bajelan E; Haeri A; Vali AM; Ostad SN; Dadashzadeh S
J Pharm Pharm Sci; 2012; 15(4):568-82. PubMed ID: 23106959
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Phase Transition Temperature on Therapeutic Efficacy of Liposomal Bortezomib.
Korani M; Nikoofal-Sahlabadi S; Nikpoor AR; Ghaffari S; Attar H; Mashreghi M; Jaafari MR
Anticancer Agents Med Chem; 2020; 20(6):700-708. PubMed ID: 31893998
[TBL] [Abstract][Full Text] [Related]
19. Effects of lipid composition and preparation conditions on physical-chemical properties, technological parameters and in vitro biological activity of gemcitabine-loaded liposomes.
Calvagno MG; Celia C; Paolino D; Cosco D; Iannone M; Castelli F; Doldo P; Frest M
Curr Drug Deliv; 2007 Jan; 4(1):89-101. PubMed ID: 17269921
[TBL] [Abstract][Full Text] [Related]
20. Formulation of Piperine-Chitosan-Coated Liposomes: Characterization and In Vitro Cytotoxic Evaluation.
Imam SS; Alshehri S; Altamimi MA; Hussain A; Qamar W; Gilani SJ; Zafar A; Alruwaili NK; Alanazi S; Almutairy BK
Molecules; 2021 May; 26(11):. PubMed ID: 34072306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
